The Canadian VirusSeq Data Portal and Duotang: open resources for SARS-CoV-2 viral sequences and genomic epidemiology.


Journal

Microbial genomics
ISSN: 2057-5858
Titre abrégé: Microb Genom
Pays: England
ID NLM: 101671820

Informations de publication

Date de publication:
Oct 2024
Historique:
medline: 14 10 2024
pubmed: 14 10 2024
entrez: 14 10 2024
Statut: ppublish

Résumé

The COVID-19 pandemic led to a large global effort to sequence SARS-CoV-2 genomes from patient samples to track viral evolution and inform the public health response. Millions of SARS-CoV-2 genome sequences have been deposited in global public repositories. The Canadian COVID-19 Genomics Network (CanCOGeN - VirusSeq), a consortium tasked with coordinating expanded sequencing of SARS-CoV-2 genomes across Canada early in the pandemic, created the Canadian VirusSeq Data Portal, with associated data pipelines and procedures, to support these efforts. The goal of VirusSeq was to allow open access to Canadian SARS-CoV-2 genomic sequences and enhanced, standardized contextual data that were unavailable in other repositories and that meet FAIR standards (Findable, Accessible, Interoperable and Reusable). In addition, the portal data submission pipeline contains data quality checking procedures and appropriate acknowledgement of data generators that encourages collaboration. From inception to execution, the portal was developed with a conscientious focus on strong data governance principles and practices. Extensive efforts ensured a commitment to Canadian privacy laws, data security standards, and organizational processes. This portal has been coupled with other resources, such as Viral AI, and was further leveraged by the Coronavirus Variants Rapid Response Network (CoVaRR-Net) to produce a suite of continually updated analytical tools and notebooks. Here we highlight this portal (https://virusseq-dataportal.ca/), including its contextual data not available elsewhere, and the Duotang (https://covarr-net.github.io/duotang/duotang.html), a web platform that presents key genomic epidemiology and modelling analyses on circulating and emerging SARS-CoV-2 variants in Canada. Duotang presents dynamic changes in variant composition of SARS-CoV-2 in Canada and by province, estimates variant growth, and displays complementary interactive visualizations, with a text overview of the current situation. The VirusSeq Data Portal and Duotang resources, alongside additional analyses and resources computed from the portal (COVID-MVP, CoVizu), are all open source and freely available. Together, they provide an updated picture of SARS-CoV-2 evolution to spur scientific discussions, inform public discourse, and support communication with and within public health authorities. They also serve as a framework for other jurisdictions interested in open, collaborative sequence data sharing and analyses.

Identifiants

pubmed: 39401061
doi: 10.1099/mgen.0.001293
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Erin E Gill (EE)

Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.

Baofeng Jia (B)

Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.

Carmen Lia Murall (CL)

Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada.
National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.

Raphaël Poujol (R)

Research Centre, Montréal Heart Institute, Montréal, QC, Canada.

Muhammad Zohaib Anwar (MZ)

Centre for Infectious Disease Genomics and One Health, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.

Nithu Sara John (NS)

Centre for Infectious Disease Genomics and One Health, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.

Justin Richardsson (J)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Ashley Hobb (A)

DNAstack, Toronto, ON, Canada.

Abayomi S Olabode (AS)

Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada.

Alexandru Lepsa (A)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Ana T Duggan (AT)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.

Andrea D Tyler (AD)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.

Arnaud N'Guessan (A)

McGill Genome Centre, McGill University, Montréal, QC, Canada.
Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montreal, QC, Canada.

Atul Kachru (A)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Brandon Chan (B)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Catherine Yoshida (C)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.

Christina K Yung (CK)

Indoc Systems, Toronto, ON, Canada.
Ontario Institute for Cancer Research, Toronto, ON, Canada.

David Bujold (D)

Department of Human Genetics, McGill University, Montréal, QC, Canada.
Canadian Centre for Computational Genomics, Montréal, QC, Canada.

Dusan Andric (D)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Edmund Su (E)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Emma J Griffiths (EJ)

Centre for Infectious Disease Genomics and One Health, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.

Gary Van Domselaar (G)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.

Gordon W Jolly (GW)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.

Heather K E Ward (HKE)

DNAstack, Toronto, ON, Canada.

Henrich Feher (H)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Jared Baker (J)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Jared T Simpson (JT)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Jaser Uddin (J)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Jiannis Ragoussis (J)

McGill Genome Centre, McGill University, Montréal, QC, Canada.

Jon Eubank (J)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Jörg H Fritz (JH)

Department of Microbiology and Immunology, McGill Research Center on Complex Traits (MRCCT), Dahdaleh Institute of Genomic Medicine (DIGM), McGill University, Montréal, QC, Canada.

José Héctor Gálvez (JH)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Karen Fang (K)

DNAstack, Toronto, ON, Canada.

Kim Cullion (K)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Leonardo Rivera (L)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Linda Xiang (L)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Matthew A Croxen (MA)

Alberta Precision Laboratories, Public Health Laboratory, Edmonton, AB, Canada.
Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada.
Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB, Canada.
Women and Children's Health Research Institute, University of Alberta, Edmonton, AB, Canada.

Mitchell Shiell (M)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Natalie Prystajecky (N)

British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, BC, Canada.
Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.

Pierre-Olivier Quirion (PO)

Canadian Centre for Computational Genomics, Montréal, QC, Canada.

Rosita Bajari (R)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Samantha Rich (S)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Samira Mubareka (S)

Sunnybrook Research Institute, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

Sandrine Moreira (S)

Université de Montréal, Montréal, QC, Canada.

Scott Cain (S)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Steven G Sutcliffe (SG)

Department of Microbiology and Immunology, McGill University, Montréal, QC, Canada.

Susanne A Kraemer (SA)

McGill Genome Centre, McGill University, Montréal, QC, Canada.
Aquatic Contaminants Research Division, ECCC, Montréal, QC, Canada.

Yelizar Alturmessov (Y)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Yann Joly (Y)

Centre of Genomics and Policy, McGill University, Montréal, QC, Canada.

Marc Fiume (M)

DNAstack, Toronto, ON, Canada.

Terrance P Snutch (TP)

Michael Smith Laboratories and Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.

Cindy Bell (C)

Genome Canada, 150 Metcalfe Street, Suite 2100, Ottawa, ON, Canada.

Catalina Lopez-Correa (C)

Genome Canada, 150 Metcalfe Street, Suite 2100, Ottawa, ON, Canada.

Julie G Hussin (JG)

Research Centre, Montréal Heart Institute, Montréal, QC, Canada.
Mila-Québec AI institute, Montréal, QC, Canada.
Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montreal, QC, Canada.

Jeffrey B Joy (JB)

Molecular Epidemiology and Evolutionary Genetics, BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Bioinformatics Programme, University of British Columbia, Vancouver, BC, Canada.

Caroline Colijn (C)

Department of Mathematics, Simon Fraser University, Burnaby, BC, Canada.

Paul M K Gordon (PMK)

Centre for Health Genomics and Informatics, University of Calgary, Calgary, AB, Canada.

William W L Hsiao (WWL)

Centre for Infectious Disease Genomics and One Health, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.

Art F Y Poon (AFY)

Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada.

Natalie C Knox (NC)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.

Mélanie Courtot (M)

Department of Medical BioPhysics, University of Toronto, ON, Canada.
Ontario Institute for Cancer Research, Toronto, ON, Canada.

Lincoln Stein (L)

Ontario Institute for Cancer Research, Toronto, ON, Canada.

Sarah P Otto (SP)

Department of Zoology and Biodiversity Research Centre, University of British Columbia, Vancouver, BC, Canada.

Guillaume Bourque (G)

Department of Human Genetics, McGill University, Montréal, QC, Canada.
Canadian Centre for Computational Genomics, Montréal, QC, Canada.

B Jesse Shapiro (BJ)

Department of Microbiology and Immunology, McGill University, Montréal, QC, Canada.

Fiona S L Brinkman (FSL)

Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH